poisar

Crypto · News reference

ClearPoint Neuro Highlights Partner Aspen Neuroscience’s RMAT Designation From FDA For Parkinson’s Therapy, Sasineprocel

BenzingaBenzinga News-desk

RMAT Designation Supports an Expedited FDA Development and Review Pathway for Aspen's Investigational Autologous Cell Replacement Therapy for Parkinson's Disease.SOLANA BEACH, CA / ACCESS Newswire / July 31,

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaAvi Kapoor

    Crude Oil Down Over 5%; McDonald's Earnings Top Views

    U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.